BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 29307014)

  • 1. Stenotrophomonas maltophilia bacteremia and pneumonia at a tertiary-care oncology center: a review of 16 years.
    Velázquez-Acosta C; Zarco-Márquez S; Jiménez-Andrade MC; Volkow-Fernández P; Cornejo-Juárez P
    Support Care Cancer; 2018 Jun; 26(6):1953-1960. PubMed ID: 29307014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical predictors of Stenotrophomonas maltophilia bacteremia in adult patients with hematologic malignancy.
    Kim SH; Cho SY; Kang CI; Seok H; Huh K; Ha YE; Chung DR; Lee NY; Peck KR; Song JH
    Ann Hematol; 2018 Feb; 97(2):343-350. PubMed ID: 29138886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparisons between patients with trimethoprim-sulfamethoxazole-susceptible and trimethoprim-sulfamethoxazole-resistant Stenotrophomonas maltophilia monomicrobial bacteremia: A 10-year retrospective study.
    Wang CH; Lin JC; Lin HA; Chang FY; Wang NC; Chiu SK; Lin TY; Yang YS; Kan LP; Yang CH; Chan MC; Yeh KM
    J Microbiol Immunol Infect; 2016 Jun; 49(3):378-86. PubMed ID: 25081988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Appropriate antibiotic therapy is a predictor of outcome in patients with Stenotrophomonas maltophilia blood stream infection in the intensive care unit.
    Lai JJ; Siu LK; Chang FY; Lin JC; Yu CM; Wu RX; Wang CH
    J Microbiol Immunol Infect; 2023 Jun; 56(3):624-633. PubMed ID: 36948945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of recurrent Stenotrophomonas maltophilia ventilator-associated pneumonia with doxycycline and aerosolized colistin.
    Wood GC; Underwood EL; Croce MA; Swanson JM; Fabian TC
    Ann Pharmacother; 2010 Oct; 44(10):1665-8. PubMed ID: 20736426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics and prognostic factors of patients with Stenotrophomonas maltophilia bacteremia.
    Lai CH; Chi CY; Chen HP; Chen TL; Lai CJ; Fung CP; Yu KW; Wong WW; Liu CY
    J Microbiol Immunol Infect; 2004 Dec; 37(6):350-8. PubMed ID: 15599467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Nosocomial Stenotrophomonas maltophilia infections in a university hospital].
    Caylan R; Yilmaz G; Sucu N; Bayraktar O; Aydin K; Kaklikkaya N; Aydin F; Köksal I
    Mikrobiyol Bul; 2005 Jan; 39(1):25-33. PubMed ID: 15900834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bloodstream infection caused by Stenotrophomonas maltophilia in children.
    Kagen J; Zaoutis TE; McGowan KL; Luan X; Shah SS
    Pediatr Infect Dis J; 2007 Jun; 26(6):508-12. PubMed ID: 17529868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stenotrophomonas maltophilia bloodstream infection in patients with hematologic malignancies: a retrospective study and in vitro activities of antimicrobial combinations.
    Cho SY; Lee DG; Choi SM; Park C; Chun HS; Park YJ; Choi JK; Lee HJ; Park SH; Choi JH; Yoo JH
    BMC Infect Dis; 2015 Feb; 15():69. PubMed ID: 25887489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors and molecular mechanisms associated with trimethoprim-sulfamethoxazole resistance in Stenotrophomonas maltophilia in Mexico.
    Herrera-Heredia SA; Pezina-Cantú C; Garza-González E; Bocanegra-Ibarias P; Mendoza-Olazarán S; Morfín-Otero R; Camacho-Ortiz A; Villarreal-Treviño L; Rodríguez-Noriega E; Paláu-Davila L; Maldonado-Garza HJ; Flores-Treviño S
    J Med Microbiol; 2017 Aug; 66(8):1102-1109. PubMed ID: 28771141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcomes of Stenotrophomonas maltophilia infection treated with trimethoprim/sulfamethoxazole, minocycline, or fluoroquinolone monotherapy.
    Junco SJ; Bowman MC; Turner RB
    Int J Antimicrob Agents; 2021 Aug; 58(2):106367. PubMed ID: 34058337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for mortality in patients with Stenotrophomonas maltophilia bacteremia and clinical impact of quinolone-resistant strains.
    Kim EJ; Kim YC; Ahn JY; Jeong SJ; Ku NS; Choi JY; Yeom JS; Song YG
    BMC Infect Dis; 2019 Aug; 19(1):754. PubMed ID: 31462215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levofloxacin-resistant Stenotrophomonas maltophilia: risk factors and antibiotic susceptibility patterns in hospitalized patients.
    Wang CH; Yu CM; Hsu ST; Wu RX
    J Hosp Infect; 2020 Jan; 104(1):46-52. PubMed ID: 31505224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successfully treated nosocomial Stenotrophomonas maltophilia bacteremia following desensitization to trimethoprim-sulfamethoxazole.
    Yilmaz M; Celik AF; Mert A
    J Infect Chemother; 2007 Apr; 13(2):122-3. PubMed ID: 17458682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emergence of concurrent levofloxacin- and trimethoprim/sulfamethoxazole-resistant Stenotrophomonas maltophilia: Risk factors and antimicrobial sensitivity pattern analysis from a single medical center in Taiwan.
    Wu RX; Yu CM; Hsu ST; Wang CH
    J Microbiol Immunol Infect; 2022 Feb; 55(1):107-113. PubMed ID: 33500210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular epidemiology and risk factors of Stenotrophomonas maltophilia infections in a Chinese teaching hospital.
    Duan Z; Qin J; Liu Y; Li C; Ying C
    BMC Microbiol; 2020 Sep; 20(1):294. PubMed ID: 32993493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sulfamethoxazole/trimethoprim versus fluoroquinolones for the treatment of Stenotrophomonas maltophilia bloodstream infections.
    Watson L; Esterly J; Jensen AO; Postelnick M; Aguirre A; McLaughlin M
    J Glob Antimicrob Resist; 2018 Mar; 12():104-106. PubMed ID: 28964955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stenotrophomonas maltophilia bacteremia in pediatric patients-- a 10-year analysis.
    Wu PS; Lu CY; Chang LY; Hsueh PR; Lee PI; Chen JM; Lee CY; Chan PC; Chang PY; Yang TT; Huang LM
    J Microbiol Immunol Infect; 2006 Apr; 39(2):144-9. PubMed ID: 16604247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of Stenotrophomonas maltophilia Infections in Critically Ill Children.
    Tokatly Latzer I; Paret G; Rubinstein M; Keller N; Barkai G; Pessach IM
    Pediatr Infect Dis J; 2018 Oct; 37(10):981-986. PubMed ID: 29634621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stenotrophomonas maltophilia bacteremia in children: risk factors and mortality rate.
    Alsuhaibani M; Aljarbou A; Althawadi S; Alsweed A; Al-Hajjar S
    Antimicrob Resist Infect Control; 2021 Jan; 10(1):19. PubMed ID: 33482916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.